FAS Wealth Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,664
| Closed | -$208K | – | 429 |
|
|
2024
Q3 | $208K | Buy |
2,664
+14
| +0.5% | +$1.09K | 0.02% | 295 |
|
|
2024
Q2 | $207K | Buy |
+2,650
| New | +$207K | 0.02% | 286 |
|
|
2023
Q2 | – | Sell |
-6,417
| Closed | -$445K | – | 413 |
|
|
2023
Q1 | $445K | Sell |
6,417
-48
| -0.7% | -$3.33K | 0.05% | 204 |
|
|
2022
Q4 | $438K | Buy |
6,465
+76
| +1% | +$5.15K | 0.05% | 208 |
|
|
2022
Q3 | $350K | Buy |
6,389
+15
| +0.2% | +$822 | 0.04% | 212 |
|
|
2022
Q2 | $421K | Hold |
6,374
| – | – | 0.04% | 198 |
|
|
2022
Q1 | $423K | Buy |
6,374
+28
| +0.4% | +$1.86K | 0.04% | 202 |
|
|
2021
Q4 | $370K | Buy |
6,346
+455
| +8% | +$26.5K | 0.03% | 226 |
|
|
2021
Q3 | $354K | Buy |
5,891
+429
| +8% | +$25.8K | 0.03% | 215 |
|
|
2021
Q2 | $327K | Hold |
5,462
| – | – | 0.03% | 224 |
|
|
2021
Q1 | $272K | Buy |
5,462
+12
| +0.2% | +$598 | 0.03% | 227 |
|
|
2020
Q4 | $272K | Buy |
5,450
+381
| +8% | +$19K | 0.03% | 219 |
|
|
2020
Q3 | $278K | Buy |
5,069
+4
| +0.1% | +$219 | 0.04% | 206 |
|
|
2020
Q2 | $268K | Hold |
5,065
| – | – | 0.04% | 201 |
|
|
2020
Q1 | $226K | Buy |
5,065
+13
| +0.3% | +$580 | 0.04% | 197 |
|
|
2019
Q4 | $252K | Hold |
5,052
| – | – | 0.04% | 177 |
|
|
2019
Q3 | $225K | Buy |
+5,052
| New | +$225K | 0.04% | 183 |
|